Prognostic value of heart rate variability in post-infarction patients

Aneta Bošković; Nataša Belada; Božidarka Knežević

doi:10.2298/3833

Aneta Bošković Clinic of Cardiology, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro
Nataša Belada Clinic of Cardiology, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro
Božidarka Knežević Clinic of Cardiology, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro

DOI: https://doi.org/10.2298/3833

Keywords: myocardial infarction, heart rate, arrhythmias, cardiac, mortality, risk factors, predictive value of tests,

Abstract

Background/Aim. Depressed heart rate variability (HRV) indicating autonomic disequilibrium and propensity to ventricular ectopy can be useful for risk stratification in patients following acute myocardial infarction (AIM). The aim of the study was to assess heart rate variability as a predictor of all-cause mortality in post-infarction patients. Methods. We analyzed the 24-hour electrocardiographic (ECG) recordings of 100 patients (80 males) during hospitalization for AIM. The mean age of patients was 56.99 + 11.03 years. Time domain heart rate variability analysis was obtained from 8 to 13 days after index infarction by mean of a 24-hour ECG recording, and the calculated parameters were: standard deviation of all normal to normal RR intervals (SDNN), RRmax-RRmin (difference between the longest RR interval and the shortest RR interval), mean RR interval. We also analyzed ventricular premature complexes from the ECG data. The patients underwent clinical evaluation, laboratory tests and echocardiography. Results. Within a one-year follow-up period 11 patients experienced death, 10 of them because of cardiac reason and one because of stroke. There were significantly lower values of SDNN (60.55 ± 12.84 ms vs 98.38 ± 28.21 ms), RRmax-RRmin (454.36 ± 111.00 ms vs 600.99 ± 168.72 ms) and mean RR interval (695.82 ± 65.87 ms vs 840.07 ± 93.97 ms) in deceased patients than in the survivors, respectively (p < 0.01). The deceased patients were of higher mean age, with lower left ventricular ejection fraction (0.46 ± 0.05 vs 0.56 ± 0.06 in survivors), and more frequent clinical signs of heart failure and ventricular ectopic activity (> 10VPCs/h; p < 0.01). Multivariate Cox analysis showed that SDNN was a significant, independent predictor of all-cause mortality in post-infarction patients. The other independent predictors were clinical signs of heart failure – Killip class II and III and ventricular ectopic activity. Conclusion. Depressed HRV is an independent predictor of mortality in post-infarction patients and may provide useful additional prognostic information in non-invasive risk stratification of these patients.

References

Andresen D, Steinbeck G, Brüggemann T, Müller D, Haberl R, Behrens S, et al. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol 1999; 33(1): 131−8.

Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Ita-liano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 1993; 88(2): 416−29.

Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocar-diographic variables and the signal-averaged electrocardio-gram. J Am Coll Cardiol 1991; 18(3): 687−97.

La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Ba-roreflex sensitivity and heart-rate variability in prediction of to-tal cardiac mortality after myocardial infarction. ATRAMI (Au-tonomic Tone and Reflexes After Myocardial Infarction) In-vestigators. Lancet 1998; 351(9101): 478−84.

Wolf MM, Varigos GA, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2(2): 52−3.

Task Force of the European Society of Cardiology and The North Amer-ican Society of Pacing and Electrophysiology. Heart rate variability Standards of measurement physiological interpretation and clinical use. Eur Heart J 1996; 17(3): 354−81.

Davis HT, DeCamilla J, Bayer LW, Moss AJ. Survivorship pat-terns in the posthospital phase of myocardial infarction. Circulation 1979; 60(6): 1252−8.

de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death inpatients with left ventricular dys-function: a meta-analysis. Eur J Heart Fail 2008; 10(10): 1007−14.

Bastiaenen R, Batchvarov V, Gallagher MM. Ventricular automa-ticity as a predictor of sudden death in ischaemic heart disease. Europace 2012; 14(6): 795−803.

Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59(4): 256−62.

Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Stas-zewsky L, et al. Prevalence and prognostic significance of ven-tricular arrhythmias after acute myocardial infarction in the fi-brinolytic era. GISSI-2 results. Circulation 1993; 87(2): 312−22.

Buccelletti E, Gilardi E, Scaini E, Galiuto L, Persiani R, Biondi A, et al. Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur Rev Med Pharmacol Sci 2009; 13(4): 299−307.

Garan H. Heart rate variability in acute myocardial infarction. Cardiology 2009; 114(4): 273−4.

Huikuri HV, Raatikainen PMJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, et al. Prediction of fatal or near-fatal car-diac arrhythmia events in patients with depressed left ventricu-lar function after an acute myocardial infarction. Eur Heart J 2009; 30(6): 689−98.

Bekheit S, Tangella M, Sakr A, Rasheed Q, Craelius W, Sherif N. Use of heart rate spectral analysis to study the effects of cal-cium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990; 119(1): 79−85.

Coumel P, Hermida JS, Wennerblöm B, Leenhardt A, Maison-Blanche P, Cauchemez B. Heart rate variability in left ventricular hyper-trophy and heart failure, and the effects of beta-blockade. A non-spectral analysis of heart rate variability in the frequency domain and in the time domain. Eur Heart J 1991; 12(3): 412−22.

Foley PW, Addison CE, Whinney SB, Patel K, Cunningham D, Frenneaux MP, et al. Implantable cardioverter defibrillator ther-apy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines. Pacing Clin Electrophysiol 2009; 32 Suppl 1: S131−4.

Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569−619.

Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, et al. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Elec-trophysiol 2010; 33(3): 320−9.

Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant CF, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Car-diol 2003; 41(9): 1573−82.

Catanchin A, Anderson L, Jones S, Ward D. When life-saving devices terminate life. J Cardiovasc Electrophysiol 2008; 19(3): 316−8.

Al-Khatib SM, Sanders GD, Bigger TJ, Buxton AE, Califf RM, Carlson M, et al. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J 2007; 153(6): 941−50.

Das MK, Maskoun W, Shen C, Michael MA, Suradi H, Desai M, et al. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 2010; 7(1): 74−80.

Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Woj-ciechowski D, et al.. Defibrillator implantation early after myo-cardial infarction. N Engl J Med 2009; 361(15): 1427−36.

Gang UJ, Jøns C, Jørgensen RM, Abildstrøm SZ, Haarbo J, Messier MD, et al. Heart rhythm at the time of death documented by an implantable loop recorder. Europace 2010; 12(2): 254−60.

Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, et al. American Heart Association/American Col-lege of Cardiology Foundation/Heart Rhythm Society scientif-ic statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 2008; 118(14): 1497−518.

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hata-la R, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351(24): 2481−8.

Huikuri HV, Stein PK. Clinical application of heart rate varia-bility after acute myocardial infarction. Front Physiol 2012; 3: 41.